Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 8:15 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–48 of 352 matching trials from the live ClinicalTrials.gov search.

Filters: Sponsor: Henry Ford Health System Clear all

Conditions: Severe Acute Respiratory Syndrome, COVID
Interventions: SARS-CoV-2 plasma; Drug
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 3
States / cities: Novi, Michigan • Southfield, Michigan • Warren, Michigan

Conditions: Breast Cancer Female
Interventions: Not listed
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years and older · Female only
Enrollment: 575 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2030
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Pressure Ulcer
Interventions: DabirAIR alternating pressure overlay; Device
Lead sponsor: Dabir Surfaces Inc; Industry
Eligibility: 18 Years and older
Enrollment: 392 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Post Operative Pain
Interventions: Continuous Infusion of ropivacaine, Intermittent bolus of ropivacaine; Drug
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years to 90 Years
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Skin Infection
Interventions: Medicinal honey, Bacitracin; Drug
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years to 100 Years
Enrollment: 17 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Novi, Michigan

Conditions: Transcatheter Aortic Valve Implantation
Interventions: Post procedure daily PT and OT, PT post procedure, OT post procedure, Routine PT or OT; Other
Lead sponsor: Henry Ford Health System; Other
Eligibility: Not listed
Enrollment: 189 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Coronary Artery Disease
Interventions: Not listed
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Carpal Tunnel Syndrome
Interventions: Corticosteroid injections for CTS treatment; Other
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years and older
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Post Inflammatory Hyperpigmentation
Interventions: Bakuchiol, Vehicle; Drug
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years to 100 Years
Enrollment: 22 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Aneurysmal Subarachnoid Hemorrhage
Interventions: Cilostazol 100 MG, Placebo; Drug · Other
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years to 100 Years
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Southfield, Michigan

Conditions: Opioid Abuse, Benzodiazepine Abuse, Polysubstance Abuse
Interventions: Morphine, Alprazolam, Placebo; Drug
Lead sponsor: Wayne State University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Labral Tear, Glenoid
Interventions: 1.5 Tesla magnet MR arthrography, 3 Tesla magnet non-contrast MRI; Radiation
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years to 65 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Royal Oak, Michigan

Conditions: Mitral Regurgitation
Interventions: PVI measurement; Device
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Covid-19
Interventions: ID NOW vs. Accula; Diagnostic Test
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years to 95 Years
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Osteoarthritis (OA) of the Knee
Interventions: Periarticular Injection, Adductor Canal Block, Bupivacaine-Meloxicam; Drug
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Grosse Pointe Farms, Michigan

Conditions: Blood Loss, Surgical, Blood Loss Anemia
Interventions: Tranexamic Acid; Drug
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years and older
Enrollment: 83 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Hepatitis C
Interventions: Interleukin 28B genotype; Genetic
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Glabellar Frown Lines
Interventions: onabotulinumtoxinA at a depth of 2mm, onabotulinumtoxinA at a depth of 4mm; Drug
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Tattoo; Pigmentation, Cancer, Treatment-Related
Interventions: Semi-Permanent Tattoo Ink; Device
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Insomnia, Nightmares Associated With Trauma and Stress, Nightmares, PTSD - Post Traumatic Stress Disorder
Interventions: Cognitive Behavioral Therapy for Insomnia, Cognitive Behavioral Therapy for Insomnia and Nightmares, Sleep Education, Sleep Education enhanced with Nightmare Education; Behavioral
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Mortality Prediction
Interventions: blood sample to check CXCL9 pre stem cell transplant and cell therapy; Diagnostic Test
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years and older
Enrollment: 124 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Xeroderma Pigmentosum
Interventions: Survey Study; Other
Lead sponsor: Henry Ford Health System; Other
Eligibility: Not listed
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Subarachnoid Hemorrhage, Hypertension
Interventions: Clevidipine butyrate injectable emulsion; Drug
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years to 80 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Non Small Cell Lung Cancer
Interventions: Nivolumab, 3D-EX, Evaluation of Response by RECIST; Drug · Diagnostic Test · Other
Lead sponsor: Nilogen Oncosystems; Industry
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Detroit, Michigan

Search by objective public record fields.

Intermediate IND Severe Illness COVID-19 CP

Assessment of Breast Cancer Patients Satisfaction and Health Related Quality of Life Outcomes

Comparative Prevention-effectiveness Trial of DabirAIR Overlay System

Intermittent Bolus vs Continuous Infusion Via ESP Catheters RCT

The Use of Medical Grade Honey in the Prevention of Bone Anchored Hearing Aid Associated Skin Breakdown

Physical Therapy and Occupational Therapy After Transcatheter Aortic Valve Replacement

Pilot Evaluation of the JHI Platform

Corticosteroid Injection Effectiveness in Carpel Tunnel Patients With Negative or Mild EMG Studies

The Efficacy of Bakuchiol in Treating PIH

Cilostazol and Nimodipine Combined Therapy After Aneurysmal Subarachnoid Hemorrhage (aSAH)

Opioid/Benzodiazepine Polydrug Abuse: Aim 3

Applicability of 3T Shoulder MRI in Detection of Labral Pathology

Pleth Variability Index (PVI) as a Measure of Volume Status During Transcatheter Mitral Valve Repair

Comparison of the ID NOW and Accula Point-of-Care Assays for Detection of COVID-19

Novel Extended-Release Bupivacaine Polymer for Sustained Pain Relief Following Total Knee Arthroplasty

Oral and Intravenous Tranexamic Acid in Lumbar Spine Surgery

Outcomes in Hepatitis C After Living Donor Liver Transplantation in Association With Interleukin 28 B

Depth of Botulinum Neurotoxin Injection for Treatment of Glabellar Lines

Feasibility of Semi-Permanent Tattoo for Treatment Alignment in Radiation Therapy

Restorative Early Sleep Treatment After the Emergency Department

BIO-FUNCTION for Prediction Non Relapse Mortality in Transplant and Cell Therapy

Xeroderma Pigmentosum Patient Experiences

Safety and Efficacy Study of Clevidipine to Control Hypertension in Patients Admitted With Aneurysmal Subarachnoid Hemorrhage

Pilot Study of Nilogen 3D-EX and Its Ability to Predict Therapeutic Response to Anti-PD1 or Anti-PDL1 in NSCLC